← SynDRA
DEUTETRABENAZINE
SynDRA canonical compound SYN0037857 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx |
|---|
| Primary target(s) | SLC18A2 |
|---|
| Mechanism of action | vesicular monoamine transporter inhibitor |
|---|
| Indication | huntington's disease |
|---|
| Disease area | neurology/psychiatry |
|---|
All known targets
Mechanisms of action (all sources)
- SLC18A2 INHIBITOR
- vesicular monoamine transporter inhibitor
- SLC18A2 MODULATOR
ATC classes
- OTHER NERVOUS SYSTEM DRUGS
Cross-references
Synonyms
- austedo
- SD 809
- Deutetrabenazina
- Dutetrabenazine
- SD-809
- Austedo
- Austedo xr
- SD809
- Deutetrabenazine [USAN:INN]
- SCHEMBL13321841
- SCHEMBL29360610
- Deutetrabenazine (USAN/INN)
- RefChem:1083217
- Austedo (TN)
- GTPL8707
- orb1706551
- orb2299908
- SCHEMBL16227993
- HY-B0590S
- TMIJ-0100
- ARD168092D6
- EX-A4770
- MFCD28964031
- AKOS040742713
- AT21717
- DA-58434
- FT167152
- MS-24810
- D10701
- T17047
- AUSTEDO XR
- AUSTEDO
Look up DEUTETRABENAZINE in the interactive SynDRA portal →